Published Date: 16 Feb 2023
Study documents huge financial costs of breast cancer treatment for women in high and low/middle income countries and offers opportunities for intervention.
Read Full NewsSusan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.
The phase 3 study aims to confirm findings from the HEALEY ALS platform trial in patients with early-stage rapidly progressive ALS, which suggested potential benefits of pridopidine across multiple domains.
Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.
Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed
1.
FDA Expands Durvalumab Label to Operable Lung Cancer
2.
Study finds primary-care doctors often overlook prostate cancer risk in Black men
3.
Cancerous breast tissue glows in new AI-enhanced MRI images
4.
Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects
5.
The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.
1.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
2.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
3.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
4.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
5.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
3.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation